Table 3. Time to hemostasis . Randomized... | American Society of Hematology

Table 3.

Time to hemostasis

	Randomized patients
	0.25 mg/kg AB023 (n = 8)		0.5 mg/kg AB023 (n = 8)		Placebo (n = 8)
	Predose*	Postdose†	Predose*	Postdose†	Predose*	Postdose†
<15 min	24/24 (100%)	24/24 (100%)	19/24 (79.2%)	19/24 (79.2%)	22/24 (92%)	21/24 (87.5%)
≥15 min	0/24 (0%)	0/24 (0%)	5/24 (20.8%)	5/24 (20.8%)	2/24 (8%)	3/24 (12.5%)

	Randomized patients
	0.25 mg/kg AB023 (n = 8)		0.5 mg/kg AB023 (n = 8)		Placebo (n = 8)
	Predose*	Postdose†	Predose*	Postdose†	Predose*	Postdose†
<15 min	24/24 (100%)	24/24 (100%)	19/24 (79.2%)	19/24 (79.2%)	22/24 (92%)	21/24 (87.5%)
≥15 min	0/24 (0%)	0/24 (0%)	5/24 (20.8%)	5/24 (20.8%)	2/24 (8%)	3/24 (12.5%)

Predose hemodialysis sessions include study day −7, −5, and −3 for a total of 24 measurements/group.

Postdose hemodialysis sessions include study day 1, 3, and 5 for a total of 24 measurements/group.